JPMorgan Cuts PT on Valeant (VRX) to $225
Tweet Send to a Friend
JPMorgan trims its price target on Valeant Pharma (NYSE ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
